BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Staging
17 results:

  • 1. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
    Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
    [No Abstract]    [Full Text] [Related]  

  • 2. [Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].
    Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
    Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):633-638. PubMed ID: 31495128
    [No Abstract]    [Full Text] [Related]  

  • 3. High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - implications for staging.
    Acuna-Villaorduna A; Gonzalez-Lugo J; Ye BH; Adrianzen Herrera DA; Sica RA; Shah U; Shah N; Kornblum N; Braunschweig I; Derman O; Mantzaris I; Shastri A; Wang Y; Verma A; Zalta B; Janakiram M
    Leuk Lymphoma; 2019 Dec; 60(13):3272-3276. PubMed ID: 31204876
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia.
    Patel A; Tiwari A; Biswas B; Chand Sharma M; Vishnubhatla S; Bakhshi S
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e291-e298. PubMed ID: 30905539
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
    Casasnovas RO; Bouabdallah R; Brice P; Lazarovici J; Ghesquieres H; Stamatoullas A; Dupuis J; Gac AC; Gastinne T; Joly B; Bouabdallah K; Nicolas-Virelizier E; Feugier P; Morschhauser F; Delarue R; Farhat H; Quittet P; Berriolo-Riedinger A; Tempescul A; Edeline V; Maisonneuve H; Fornecker LM; Lamy T; Delmer A; Dartigues P; Martin L; André M; Mounier N; Traverse-Glehen A; Meignan M
    Lancet Oncol; 2019 Feb; 20(2):202-215. PubMed ID: 30658935
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Multiple primary non-breast tumors in breast cancer survivors.
    Corso G; Veronesi P; Santomauro GI; Maisonneuve P; Morigi C; Peruzzotti G; Intra M; Sacchini V; Galimberti V
    J Cancer Res Clin Oncol; 2018 May; 144(5):979-986. PubMed ID: 29502170
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Natural history of t(11;14) multiple myeloma.
    Lakshman A; Alhaj Moustafa M; Rajkumar SV; Dispenzieri A; Gertz MA; Buadi FK; Lacy MQ; Dingli D; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Hwa YL; Kapoor P; Leung N; Go RS; Lin Y; Kourelis TV; Lust JA; Russell SJ; Zeldenrust SR; Kyle RA; Kumar SK
    Leukemia; 2018 Jan; 32(1):131-138. PubMed ID: 28655925
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
    Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
    Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
    JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
    Srivastava G; Rana V; Lacy MQ; Buadi FK; Hayman SR; Dispenzieri A; Gertz MA; Dingli D; Zeldenrust S; Russell S; McCurdy A; Kapoor P; Kyle R; Rajkumar SV; Kumar S
    Leukemia; 2013 Oct; 27(10):2062-6. PubMed ID: 23648667
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Methylation status of DDIT3 gene in chronic myeloid leukemia.
    Wang YL; Qian J; Lin J; Yao DM; Qian Z; Zhu ZH; Li JY
    J Exp Clin Cancer Res; 2010 May; 29(1):54. PubMed ID: 20492726
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Over 30-year experience of Polish Pediatric leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():33-9. PubMed ID: 15688474
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Blood transfusion as a risk factor for non-Hodgkin lymphoma.
    Brandt L; Brandt J; Olsson H; Anderson H; Möller T
    Br J Cancer; 1996 May; 73(9):1148-51. PubMed ID: 8624279
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
    Koziner B; Myers J; Cirrincione C; Redman J; Cunningham I; Caravelli J; Nisce LZ; McCormick B; Straus DJ; Mertelsmann R
    Am J Med; 1986 Jun; 80(6):1067-78. PubMed ID: 3755285
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MOPP chemotherapy plus irradiation for Hodgkin's disease, stages IA to IIIB. Long-term results of the prospective trial H72 (1972-1976, 334 patients).
    Andrieu JM; Dana M; Desprez-Curely JP; Jacquillat C; Weil M
    Hematol Oncol; 1985; 3(4):219-31. PubMed ID: 3841333
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.